INTRODUCTION
to the mitogenic effect on endothelial cells. It increases endothelial cell permeability, facilitates monocytes penetration, and enhances synthesis of plasminogen activa-The efficacy of hepatocytes transplantation is dependent on the ability of cells to engraft and function within tor (PA) and PA inhibitor in endothelial cells (9, 21) . VEGF has, in addition, a vasodilatatory effect mediated the recipient liver. This ability is driven by various mechanical and biochemical factors such as blood vessel by NO (33). Its bioactivity is mediated through tyrosine kinase receptors (VEGFR1-Flt-1, VEGFR2-KDR/Flk-1) size, blood flow, and growth factors (12).
Low efficiency of cell engraftment and a low poten- (22) . VEGF expression is stimulated by hypoxia, cytokines, various hormones, and hypoglycemia (16,28). tial of transplanted cells to proliferate are among the factors delaying the clinical use of this technique. At pres-In the liver, receptors are found on endothelial cells and VEGF can be found in a small quantity within liver ent, it is believed that 10-20% of the normal hepatocyte mass is required to allow the liver to function within nor-cells (32). VEGF, secreted by replicating hepatocytes, induces sinusoidal endothelial cell proliferation during mal physiological parameters, whereas cell transplantation efficiency is only between 5% and 20% (8, 17, 23, 31) .
regeneration after partial hepatectomy in rats (27) . VEGF expression increased in hepatocytes and in nonparenchy-Therefore, optimization of cell engraftment may help increase liver repopulation. mal cells following 70% PHP (19) . Furthermore, sinusoidal endothelial cells (SEC) increase expression of the VEGF 165 has a wide range of activities, in addition 50 SHANI-PERETZ ET AL. receptors flt-1 and KDR/flk-1 and proliferate following thesia at 24 and 48 h posttransplantation and after 2 weeks. Blood was taken from the heart. The liver and 70% PHP (27) . VEGF has been shown, in vivo and in vitro, to have a role in accelerating hepatocyte prolifera-spleen were exteriorized and tissue samples were frozen immediately in liquid nitrogen for PCR analysis and tion, along with various growth factors (4,16,30). It was described that VEGF is released by both host and trans-other specimens were fixed in 4% buffered formalin followed by paraffin embedding. planted hepatocytes during cell entry into the liver plate (29). Other studies with hepatocyte transplantations DNA Purification and PCR showed that the expression of VEGF in transplanted hepatocytes enhanced tissue vascularity as well as the growth Tissue samples from the remnant left lobe of the liver were frozen in liquid nitrogen and stored at −70°C. and colonization of the transplanted hepatic tissue (2). Based on the above-mentioned data, we assumed that DNA purification was carried out by phenol chloroform method (Master Pure DNA Purification Kit, Epicenter VEGF could have an overall permissive effect on transplanted hepatocyte engraftment.
Biotechnology, Israel).
MATERIALS AND METHODS

Detection of Male-Derived Cells Animals
Oligonucleotide primers were selected using gene sequence analysis software (GenBank, accession numbers Thirty-two female adult Lewis syngeneic rats, weighare X89730.1 and AY157670.1) for the rat SRY gene ing 180-200 g, were used. Animals were housed in a and were prepared by MBC (Molecular Biology Center, temperature-and humidity-controlled environment with Ltd., Rechovot, Israel). a 12-h light-dark cycle and maintained on standard rat Nested PCR analysis in two steps using primers to chow and water ad libitum until the day before surgery.
the SRY gene, on the Y chromosome of the rat, was Twelve hours postsurgery rats received 20% glucose done for detection of male-derived cells. PCR amplificawater for drinking. Male rats served as cell donors, and tion was carried out in a Biometra thermal cycler in mifemale rats served as recipients. The protocol was apcrotubes. The PCR reaction mixture consisted of 500 ng proved by the Animal Ethics Committee at the Techtarget DNA, 2 mM of each dNTP, PCR buffer (10×) nion. All animals received humane care according to the containing 2.5 mM MgCl 2 , and 0.1 µg/µl of Taq DNA ethics committee guidelines. polymerase (reagents for PCR were purchased from Hepatocyte Isolation Eisenberg Brothers Ltd., Israel). Thirty-three amplification cycles were performed. Each cycle consisted of a Hepatocytes were isolated by modified two-step coldenaturing step at 95°C for 1 min, an annealing step at lagenase perfusion method (6,25). Hepatocyte viability 53°C for 1 min, and an extension step at 72°C for 1 was determined by trypan blue exclusion assay. Cells min; an additional extension was performed at 72°C for were used only when viability exceeded 90% after isola-10 min. The first PCR product, 440 base pairs (bp), was tion.
obtained using primers with the following sequence: 5′-Surgery and Cell Transplantation TCT ACT CCA GTC TTG TCC-3′ and 5′-TAG TGT TCA GCC CTA CAG-3′. The second PCR product was Thirty-two female rats underwent 70% PHP under ether anesthesia and local lidocaine anesthesia (15). obtained using primers with the following sequences: 5′-AAT CTC TGG AGA AGG GAC-3′ and 5′-GTG TGT Briefly, the liver was exposed through a 2-cm midline abdominal incision and the two anterior lobes were exte-AGG TTG TTG TCC-3′. The size of the second PCR product was 380 bp (1). Final PCR product was ana-riorized, ligated, and excised. Administration of hVEGF 165 (240 ng), in 0.5 ml saline, was carried out by injection lyzed on a 2% agarose gel stained with ethidium bromide by electrophoresis. The β-actin gene generated by into the spleen pulp before cell transplantation. The dose of hVEGF 165 was chosen arbitrarily based on our previ-PCR (Molecular Biology Center, Ltd.) was used as control. Semiquantitative analysis of PCR product was car-ous observation showing a significant in vivo effect on hepatocyte proliferation (3). Control rats underwent 70% ried out by densitometry for detection of transplanted male cells in the recipient liver. PCR analysis was re-PHP and received an identical volume (0.5 ml) of isotonic saline at the same time intervals. Following VEGF/ peated three times. The results of densitometry were expressed as the mean of two to three determinations. saline administration, 10 7 male hepatocytes within DMEM (Biological Industries LTD, Israel) were transplanted
The basis for calculating the number of cells after densitometry was done after preliminary determination into the spleen parenchyma. Immediately postsurgery, rats received subcutaneously 10 cc of 5% glucose water. that 0.5 µg of DNA contains approximately 4.8 × 10 3 harvested hepatocytes. All calculations were done for Cell transplantation was carried out between 1300 and 1500 h. Rats were sacrificed under phenobarbital anes-0.5 µg of DNA and extrapolated to 1 g of liver. Tissue Staining dition of a biotinylated secondary antibody. Diaminobenzidene was used as substrate-chromogen solution. Paraffin-embedded liver sections (4 µm) were stained Slides were counterstained by hematoxylin. PCNA imfor hematoxylin and eosin (H&E). Transplanted cells munostaining was estimated as a percentage of positive were identified in portal vessels. They were clearly idennuclei of hepatocytes in 10 random fields (magnification tified by a different cell orientation and by the absence ×40). of intracellular fat, which is prominent in hepatocytes after PHP. Portal veins filled with hepatocytes were
Biochemical Analysis counted and expressed as percentage of the total portal Arterial blood was taken from the heart at the time tracts counted in each slide. Mean portal tract counted of sacrifice. Serum was obtained for analysis by centrifper animal was 12 ± 6. ugation of whole blood for 5 min at 1500 rpm. Biochem-Proliferating Cell Nuclear Antigen ical analyses were carried out at the Rambam Medical (PCNA) Immunostaining
Center, Biochemical Laboratory. Tests were done for the following: aspartate aminotransferase (AST), alanine PCNA immunostaining was carried out with Histosamino transferase (ALT), lactate dehydrogenase (LDH), tain-Plus DAB kit (Zymed Laboratories Inc., Israel).
total bilirubin, and albumin. Briefly, paraffin-embedded liver tissue sections were deparaffinized and rehydrated. Endogenous peroxidase ac-Statistical Analysis tivity was quenched by treating tissue sections with 3% H 2 O 2 in absolute methanol followed by microwave heat-
The significance of differences was analyzed with the Mann-Whitney Rank Sum Test (Systat 7.0). A value of ing with 5 mM citric acid for 5 min at 90°C. Slides were incubated with the anti-PCNA antibody followed by adp < 0.05 was considered significant. contact to endothelial cells of the portal veins can be observed (Fig. 3B ). There was no histological sign of injury to adjacent tissue. By 48 h, cells were already in continuity with the hepatocytes of the recipient liver (Fig. 3C ). Twenty-four hours after VEGF treatment, transplanted cells within portal vessels were identified in four out of five rats, and in only one out of three salinetreated rats (p < 0.05). In the VEGF group at 24 h, when referring to the total number of portal tracts counted (13 ± 4), then 5 ± 4 out of them were filled with transplanted cells compared to 5 out of 17 portal tracts counted in only one control rat (Fig. 4) . At 48 h, in the VEGF-treated rats but none in the controls, the number treated rats.
PCNA Analysis
We carried out PCNA immunostaining for detection RESULTS of liver regeneration activity and proliferative capacity Number of Transplanted Cell as Analyzed by PCR of transplanted and recipient liver cells ( Fig. 5A ) (5).
Within Whole Liver
There was no positive staining in transplanted cells within Detection of male transplanted cells was done by the portal radicles to suggest proliferation of trans-PCR analysis of DNA extracted from recipient livers planted hepatocytes within the vessels (Fig. 5B ). The after cell transplantation. The amount of male DNA in proliferation rate of hepatocytes was not different beeach recipient liver was translated to the number of cells tween VEGF-treated and control rats as expressed by in each organ (expressed as number of cells per gram of labeling index for PCNA (data not shown). Numerous liver tissue). The mean ± SEM number of cells was 0.9 PCNA-positive endothelial cells were identified mainly ± 1.3 × 10 5 in the VEGF-treated rats at 24 h and was not at 48 h after transplantation, whereas significantly fewer detected in the saline control rats (Fig. 1) . It was higher cells were stained at 24 h (Fig. 5B ). The number of 24 h after transplantation than after 48 h (p = NS). The PCNA-stained nuclei of endothelial cells in both groups significant high number of cells by PCR in one rat in was very low with a tendency to a higher number of the control group at 48 h (more than 3 SD above the positive cells in the VEGF-treated rats (Fig. 6 ). mean) was excluded from any calculations except for Biochemical Analysis the presence of cells within the portal tracts. At 14 days after transplantation two out of four VEGF-treated rats A significant increase in AST and LDH was detected versus one out of six controls had transplanted hepato-24 h posttransplantation in serum of VEGF-treated rats cytes in the recipient liver with values of 2.27 ± 1.31 × compared with the control group. At 48 h posttransplan-10 5 versus 0.65 ± 0.6 × 10 5 , respectively (p = NS). Figtation a significant decrease in AST and LDH was deure 2 represents an example of the PCR analysis for tected in VEGF-treated rats but not in the control group. detection of transplanted cells 2 weeks following trans-Bilirubin was low in the VEGF-treated rats and albumin plantation. levels were comparable. Two weeks after transplantation both bilirubin and albumin returned to normal levels and Histological Analysis: Late Presence of Transplanted liver enzymes were only slightly increased (Table 1) .
Cells in Portal Vein Radicles
DISCUSSION One rat in addition to the study groups was sacrificed 25 min posttransplantation. Transplanted hepatocytes Long-term presence of transplanted cells within portal vessels enhanced by VEGF is an important observa-were seen within portal vein radicles by that time, with erythrocytes scattered in between (Fig. 3A) . Twenty-four tion noted in this study. These results favor a different mechanism by which transplanted cells engraft into the hours posttransplantation cells were located as aggregates within portal vessels and scattered apoptotic cells recipient liver. The common concept is that cells are engrafted to the liver parenchyma as isolated cells via can still be seen in between the cells (Fig. 3B) . Close the liver sinusoids after damage to the sinusoidal wall tion (12,14). Normally, parenchymal cells would not survive within vessels with high blood flow (11). We (13).
It is believed that transplanted cells localized to por-show here that following partial hepatectomy and VEGF administration, cells attach to each other and form tal vessels are eliminated by macrophages and polymorphonuclear leukocytes within 12-24 h posttransplanta-groups within the portal vessels and survive there proba-
We are not sure whether hemodynamic changes occurring in our model favor hepatocyte transplantation after partial hepatectomy. Following 70% partial hepatectomy there is an increase in portal pressure and a decrease in portal blood flow (20, 24) . Portal hypertension increases following cell transplantation, resolving within hours after the procedure (13). We therefore speculate that following partial hepatectomy and cell transplantation, a cluster attachment of the transplanted cells forms a new microenvironment at the portal venule radicles, lowering blood flow, allowing the migration into the parenchyma. This hypothesis concerning the mechanism of cell engraftment has an important implication for the future approach to improving engraftment. It is apparent n=9 n=5 that further reduction of portal pressure may lessen shear The part VEGF takes in this process is not clear. We have used hVEGF 165 initially for several reasons. It was found in vivo to accelerate hepatocyte regeneration in bly until they translocate to the liver parenchyma diaddition to being a strong angiogenic stimulant (3,30). rectly, not via the sinusoids. The mechanism by which VEGF 165 is an abundant form of the VEGF isoforms. It these cells enter the parenchyma is by inclusion and not is secreted, but also remains bound to cell surfaces and by occlusion and tissue disintegration. The inclusion extracellular matrix, and this may prolong its action process occurs by the formation of new vessels, bypass-(10). There is evidence from in vivo studies that VEGF ing the cell aggregates. This latter mechanism is stimu-mRNA is increased in the regenerating liver within the lated by VEGF. The relatively long-term presence of first 24-48 h and this parallels the increased angiogenhealthy hepatocytes without signs of ischemia or tissue esis (19, 24, 27) . Moreover, an inhibitory effect with antidamage supports this view. This observation explains VEGF already occurs within hours after administration why transplanted cells are usually seen in groups close (30) . Therefore, the timetable as presented in these in to the portal areas, as seen in other studies (29). The vivo studies supports the possibility of having, in our long-term results of our experiments support this constudy, an early proliferative effect of the administered cept as a trend for better engraftment was seen with VEGF in addition to the endogenous one. The endoge-VEGF treatment. Yet the mechanisms that favor longnous VEGF production was recently shown to be more term survival are not necessarily those that affect early prominent around the periportal area (28) . A proliferative effect on sinusoidal endothelial cells was seen in integration. is enhanced by VEGF and studies in vivo showed a
